Scaleable Platform for Radically Open Pharmaco-biology

What is the most undervalued area for longevity progress we should pursue?Data as a satellite product.Where are we today? Where would we like to be?Today we have data as a big bad entity that must be handled by specialists. We must first acknowledge the problem and be honest about how things really are. Then we can create data quality controls and standardization to make it easier to deal with large volumes of data.What public and private actions have the biggest impact on those goals?Government and NIST engaging with data quality improvement, and pilot projects creating low-cost federated longevity testing platforms.What people, funding, resources, experiments would be required to test this hypothesis?It may be possible to generate funding via the creation of a data token reward system.